OAB and Incontinence

>

Latest News

Survey data highlights substantial impact of postpartum incontinence
Survey data highlights substantial impact of postpartum incontinence

February 11th 2025

Overall, 85% of respondents indicated they experienced frequent bladder leaks.

Published OASIS data show durable efficacy of Revi System for UUI
Published OASIS data show durable efficacy of Revi System for UUI

February 7th 2025

ROBUST I: Optilume maintains durable efficacy, safety for urethral strictures
ROBUST I: Optilume maintains durable efficacy, safety for urethral strictures

January 20th 2025

Sunobinop shows promise in phase 1b trial for overactive bladder
Sunobinop shows promise in phase 1b trial for overactive bladder

January 7th 2025

FDA approves vibegron for OAB symptoms in pharmacologically treated BPH
FDA approves vibegron for OAB symptoms in pharmacologically treated BPH

December 23rd 2024

Video Series
Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.